Gerard R. Colca

Co-Founder at Metabolic Solutions Development Co. LLC

Gerard R. Colca

Gerard R. Colca

Co-Founder at Metabolic Solutions Development Co. LLC

Overview
Career Highlights

Metabolic Solutions Development Co. LLC

RelSci Relationships

495

Number of Boards

2

Relationships
RelSci Relationships are individuals Gerard R. Colca likely has professional access to. A relationship does not necessarily indicate a personal connection.

Co-Founder at Metabolic Solutions Development Co. LLC

Relationship likelihood: Strong

Co-Founder at GA Holding Co. LLC

Relationship likelihood: Strong

Co-Founder at QuatRx Pharmaceuticals Co.

Relationship likelihood: Strong

Manager at SWMF Life Science Fund GP LLC

Relationship likelihood: Strong

Chief Executive Officer at Metabolic Solutions Development Co. LLC

Relationship likelihood: Strong

Fund Advisor at Hopen LS Manager II LLC

Relationship likelihood: Strong

Chief Executive Officer at Cirius Therapeutics, Inc.

Relationship likelihood: Strong

Fund Advisor at Hopen LS Manager II LLC

Relationship likelihood: Strong

Chief Scientific Officer & Co-Founder at Phathom Pharmaceuticals, Inc.

Relationship likelihood: Strong

Vice President-Development at Cirius Therapeutics, Inc.

Relationship likelihood: Strong

Paths to Gerard R. Colca
Potential Connections via
Relationship Science
You
Gerard R. Colca
Co-Founder at Metabolic Solutions Development Co. LLC
Education
Ph.D Physiology/Biochemistry

University of Houston System offers higher education degrees and job training or vocational study programs. It offers about 280 undergraduate and graduate degree programs in fields such as business, education, humanities and law. It was founded in 1927 and is headquartered in Houston, TX.

Memberships
Member
Current

The American Diabetes Association is leading the fight to Stop Diabetes® and its deadly consequences and fighting for those affected by diabetes. The Association funds research to prevent, cure and manage diabetes; delivers services to hundreds of communities; provides objective and credible information; and gives voice to those denied their rights because of diabetes. Founded in 1940, the Association's mission is to prevent and cure diabetes, and to improve the lives of all people affected by diabetes.

Member
Current

The New York Academy of Sciences is a membership organization with over 25,000 members in 140 countries. They include research scientists at universities and industry, as well as representatives of business, government, and policy organizations. Our Board of Governors and President's Council include 27 Nobel laureates and other prominent leaders of academia and industry, based in New York and around the world.

Member
Current

The American Society for Biochemistry and Molecular Biology (ASBMB) is a nonprofit scientific and educational organization with over 12,000 members. Founded in 1906, the Society is based in Rockville, Maryland. The Society's purpose is to advance the science of biochemistry and molecular biology through publication of scientific and educational journals: the Journal of Biological Chemistry, Molecular & Cellular Proteomics, and the Journal of Lipid Research, organization of scientific meetings, advocacy for funding of basic research and education, support of science education at all levels, and promoting the diversity of individuals entering the scientific workforce.

Career History
Co-Founder
2006 - Current

Metabolic Solutions Development Co. LLC operates as a drug discovery and development company. It develops novel therapeutics to treat metabolic diseases associated with age-related mitochondrial dysfunction, especially insulin resistance and type 2 diabetes. The company was founded by Jerry Colca and Rolf Kletzien in 2006 and is headquartered in Kalamazoo, MI.

Scientist
Prior

Pfizer Inc. engages in the discovery, development, and manufacture of healthcare products specializes in medicines, vaccine, and consumer healthcare. It operates through the Pfizer Innovative Health (IH) and Pfizer Essential Health (EH) segments. The IH segment focuses on the development and commercializing medicines and vaccines for internal medicine, oncology, inflammation and immunology, rate disease, and consumer healthcare. The EH segment is involved in development and supply of branded generics, generic sterile injectable products, biosimilars, and select branded products including anti-infectives. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.

Scientist
1984 - Prior
Boards & Committees
Member, Scientific Advisory Board
Current

Cirius Therapeutics, Inc. operates as a biotechnology company. It offers metabolic treatment for nonalcoholic steatohepatitis. The company was founded by Jerry R. Colca and Brian Finck and was founded in March 2017, and is headquartered in San Diego, CA.

Member, Board of Managers
2006 - ?

Metabolic Solutions Development Co. LLC operates as a drug discovery and development company. It develops novel therapeutics to treat metabolic diseases associated with age-related mitochondrial dysfunction, especially insulin resistance and type 2 diabetes. The company was founded by Jerry Colca and Rolf Kletzien in 2006 and is headquartered in Kalamazoo, MI.

Transactions
Details Hidden

Metabolic Solutions Development Co. LLC raised money in a private placement transaction

Details Hidden

Metabolic Solutions Development Co. LLC raised money in a private placement transaction

Details Hidden

Metabolic Solutions Development Co. LLC raised money in a private placement transaction

Investments
Details Hidden

Cirius Therapeutics, Inc. operates as a biotechnology company. It offers metabolic treatment for nonalcoholic steatohepatitis. The company was founded by Jerry R. Colca and Brian Finck and was founded in March 2017, and is headquartered in San Diego, CA.

Details Hidden

Metabolic Solutions Development Co. LLC operates as a drug discovery and development company. It develops novel therapeutics to treat metabolic diseases associated with age-related mitochondrial dysfunction, especially insulin resistance and type 2 diabetes. The company was founded by Jerry Colca and Rolf Kletzien in 2006 and is headquartered in Kalamazoo, MI.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Gerard R. Colca. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Gerard R. Colca's profile does not indicate a business or promotional relationship of any kind between RelSci and Gerard R. Colca.